Cargando…
Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma
Cisplatin is one of the most potent chemotherapy drugs widely used for cancer treatment. However, due to resistance and toxicity, the application of cisplatin for the treatment of hepatocellular carcinoma (HCC) is limited. Our previous study has shown that granulin A (GRN A), an anticancer peptide,...
Autores principales: | Qiao, Gan, Xu, Huanli, Li, Cong, Li, Xiao, Farooqi, Ammad Ahmad, Zhao, Yuming, Liu, Xiaohui, Liu, Ming, Stagos, Dimitrios, Lin, Xiukun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213591/ https://www.ncbi.nlm.nih.gov/pubmed/30301274 http://dx.doi.org/10.3390/ijms19103060 |
Ejemplares similares
-
Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Pancreatic Cancer by Inducing Autophagy Through AMPK/mTOR Pathway
por: Li, Xiao, et al.
Publicado: (2019) -
Interaction between granulin A and enolase 1 attenuates the migration and invasion of human hepatoma cells
por: Chen, Xiaoliang, et al.
Publicado: (2017) -
Recent progress in fungus-derived bioactive agents for targeting of signaling machinery in cancer cells
por: Lin, Xiukun, et al.
Publicado: (2015) -
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
por: Zhou, Bo, et al.
Publicado: (2019) -
Folding of Truncated Granulin Peptides
por: Takjoo, Rozita, et al.
Publicado: (2020)